You have 9 free searches left this month | to do more
Showing 1 - 25 of
390 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients
Enrolling by invitation
  • Premature Ovarian Failure
  • Fayoum, Mesala, Egypt
    Beni Suef university
2021-12-07
Dec 7, 2021
E
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer
Recruiting
  • Advanced Prostate Cancer
  • Inj. Goserelin (Test) Subcutaneously
  • Inj. Zoladex (Reference) Subcutaneously
  • Visakhapatnam, Andhra Pradesh, India
    Mahatma Gandhi Cancer Hospital & Research Institute
2022-01-26
Jan 26, 2022
E
Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer
Recruiting
  • Breast Cancer
  • Goserelin acetate 3.6 mg Injection
  • ZOLADEX® 3.6mg Injection
  • Visakhapatnam, Andhra Pradesh, India
    Mahatma Gandhi Cancer Hospital & Research Institute
2022-01-26
Jan 26, 2022
L
Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
Recruiting
  • Breast Cancer
  • Hangzhou, China
    Zhejiang Cancer Hospital
2021-11-03
Nov 3, 2021
L
Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® - 2021
Completed
  • Prostate Cancer
  • LY01005 3.6 mg
  • ZOLADEX® 3.6 mg
  • Shanghai, China
    Fudan University Shanghai Cancer Center
2021-08-20
Aug 20, 2021
L
Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
Active, not recruiting
  • Prostate Cancer
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
2021-11-19
Nov 19, 2021
S
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer - 2015
Completed
  • Prostate Cancer
  • Denver, Colorado
  • +2 more
2021-09-30
Sep 30, 2021
C
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer - 2018
Completed
  • Prostate Cancer
  • Goserelin Acetate
  • Abbotsford, British Columbia, Canada
  • +6 more
2021-05-06
May 6, 2021
A
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients - 2004
Completed
  • Early-stage Breast Cancer
  • (no location specified)
2020-10-13
Oct 13, 2020
H
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer - 2021
Completed
Has Results
  • Breast Cancer
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2022-01-13
Jan 13, 2022
U
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin - 2017
Terminated
  • Uterine Leiomyoma
  • (no location specified)
2020-08-11
Aug 11, 2020
W
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Recruiting
  • Breast Cancer
  • +3 more
  • FACT-B
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-09
Feb 9, 2022
N
Roll-over Study to Allow Continued Access to Ribociclib
Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
2022-04-04
Apr 4, 2022
I
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Goserelin
  • +3 more
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
2021-05-14
May 14, 2021
C
Degarelix in the Treatment of Endometriosis Recurrence - 2016
Completed
  • Endometriosis
  • Tirana, Albania
  • +2 more
2022-02-10
Feb 10, 2022
P
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients
Recruiting
  • Breast Cancer
  • Goserelin 3.6 MG
  • Beijing, Beijing, China
    Peking University People's Hospital
2020-05-18
May 18, 2020
S
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
Recruiting
  • Metastatic Prostate Cancer
  • Androgen Deprivation Therapy
  • GnRH agonist
  • Seattle, Washington
    Veterans Affairs Puget Sound Health Care System
2022-03-16
Mar 16, 2022
N
Neoadjuvant Treatment of Breast Cancer
Not yet recruiting
  • Breast Cancer
  • Budapest, Hungary
    National Institute of Oncolgy
2021-11-20
Nov 20, 2021
N
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Active, not recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +22 more
2022-04-04
Apr 4, 2022
S
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2020-12-07
Dec 7, 2020
M
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • (no location specified)
2022-01-05
Jan 5, 2022
T
Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
2021-12-30
Dec 30, 2021
A
Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin
Recruiting
  • Breast Neoplasms
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
2021-08-05
Aug 5, 2021
M
Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women - 2009
Completed
  • Bioequivalence
  • (no location specified)
2021-11-05
Nov 5, 2021
P
COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg - 2020
Completed
  • Dysfunctional Uterine Bleeding
  • Pepti 3.6 mg
  • Kyiv, Ukraine
  • +4 more
2020-06-09
Jun 9, 2020